Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study

Abstract We investigated the potential of mid-regional pro-adrenomedullin (MR-proADM) for use as a novel biomarker for arterial stiffness as the criterion for vascular failure and cardiometabolic disease (obesity, hypertension, dyslipidemia, diabetes, and metabolic syndrome) compared with high-sensi...

Full description

Bibliographic Details
Main Authors: Teruhide Koyama, Nagato Kuriyama, Yosuke Suzuki, Satoshi Saito, Ryota Tanaka, Motoshi Iwao, Megumu Tanaka, Takakuni Maki, Hiroki Itoh, Masafumi Ihara, Takayuki Shindo, Ritei Uehara
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-79525-2

Similar Items